WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta Biosciences, a clinical-stage biotechnology company developing novel drugs that use immune-modulating nanomedicines based on Synthetic Vaccine Particles (SVP™), announced today that Werner Cautreels, PhD, President and CEO, will present a company overview at the Needham & Company’s 14th Annual Healthcare Conference on Tuesday, April 14, 2015, at 11:40 am EDT in New York City.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
